Skip to content
Black Friday — 30% OFFFree shipping on orders of £99 or more
  1. Home
  2. Weight Management & Metabolism
  3. Orforglipron
Weight Management

Orforglipron

Orforglipron · Oral small-molecule GLP‑1 receptor agonist

An oral, non-peptide GLP‑1 receptor agonist. Not a peptide.

Original price was: £265.Current price is: £185.50.

Available on request in the United Kingdom

Ask an advisor
An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorised telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • USPS Regular Shipping · £11.95 · Approx. 3–5 business days
  • FedEx 2 Days Delivery · £28.99 · Approx. 2 business days
  • FedEx Overnight Delivery · £40.99 · Approx. 1 business day
Research status

What is known so far

Orforglipron is an oral small-molecule (non-peptide) GLP‑1 receptor agonist developed for obesity and type 2 diabetes.

Its authorisation status in the United Kingdom is under review. This page is informational only and does not describe proven clinical benefits.

Documents

Product information

Patient information leafletNot available: authorisation status under review
Summary of Product CharacteristicsNot available: authorisation status under review
References

Sources

  1. US Food and Drug Administration. Novel Drug Approvals for 2026: Foundayo (orforglipron), 1 April 2026.
Original price was: £265.Current price is: £185.50.